NovoCure
NVCR
Reported
Wednesday, October 30
Q3 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.33 | -0.28 | 0.05 | 15.15% |
| Revenue | 144M | 155M | 11.1M | 7.74% |
WhatIF - Earnings
EPS Beat Expectations by $0.05
NovoCure (NVCR:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything